Statement of Changes in Stockholders’ Equity - 9 months ended Dec. 31, 2020 - USD ($)		Class A Common Stock	Class B Convertible Common Stock	Additional Paid-in Capital	Accumulated Deficit	Total
Balance at Mar. 18, 2020
Balance (in Shares) at Mar. 18, 2020
Issuance of Founder Shares to Sponsor	[1]		$ 503	24,497		25,000
Issuance of Founder Shares to Sponsor (in Shares)	[1]		5,031,250
Sale of Class A common stock in initial public offering, net of warrant liabilities		$ 1,750		166,160,750		166,162,500
Sale of Class A common stock in initial public offering, net of warrant liabilities (in Shares)		17,500,000
Offering costs				(9,454,542)		(9,454,542)
Founder Shares forfeited due to non-exercise of over-allotment option			$ (66)	66
Founder Shares forfeited due to non-exercise of over-allotment option (in Shares)			(656,250)
Common stock subject to possible redemption		$ (1,508)		(150,769,712)		(150,771,220)
Common stock subject to possible redemption (in Shares)		(15,077,122)
Net loss					(961,729)	(961,729)
Balance at Dec. 31, 2020		$ 242	$ 437	$ 5,961,059	$ (961,729)	$ 5,000,009
Balance (in Shares) at Dec. 31, 2020		2,422,878	4,375,000

[1] On August 3, 2020, the Company effected a 1.4-for-1 forward stock split of its issued and outstanding shares of Class B convertible common stock. All shares and associated amounts have been retroactively restated to reflect the forward stock split (see Note 6).